Determinants of successful opioid deprescribing: Insights from French pain physicians—A qualitative study
Pain Practice · 2025
DOI: 10.1111/papr.13409 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pain Practice, 2025. Verfasst von Pierre Nizet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, CHU Nantes, Pharmacie, Nantes, France. Hauptthemen laut MEDLINE: Analgesics, Opioid, Deprescriptions, Chronic Pain, Physicians. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background
Long‐term use of opioids does not result in significant clinical improvement and has shown more adverse than beneficial effects in chronic pain conditions. When opioids cause more adverse effects than benefits for the patient, it may be necessary to initiate a process of deprescribing.
Aim
To explore the perceptions of French pain physicians regarding the process of opioid deprescribing in patients experiencing chronic non‐cancer and to generate an understanding of the barriers and levers to the deprescribing process.
Methods
We conducted a multicentric observational study with qualitative approach. Individual semi‐structured interviews exploring pain physicians' perceptions, beliefs, and representations to assess the determinants of opioid deprescribing with an interview guide were used. After checking the transcripts, an inductive and independent thematic analysis of the interviews was to extract meaningful themes from the dataset.
Results
Twelve pain physicians were interviewed. The main obstacles to deprescribing revolved around patient‐specific attributes, characteristics of the opioids themselves, and limitations within the current healthcare system, that hinder optimal patient management. Conversely, patient motivation and education, recourse to hospitalization in a Pain Department with multidisciplinary care, follow‐up by the general practitioner, and training and information dissemination among patients and clinicians emerged as facilitative elements for opioid deprescribing.
Conclusion
This study underscores the needs to improve the training of healthcare professionals, the effective communication of pertinent information to patients, and the establishment of a therapeutic partnership with the patient. It is therefore essential to carry out the deprescribing process in a collaborative and interprofessional manner, encompassing both pharmaceutical and non‐pharmaceutical strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nantes Université, CHU Nantes, Pharmacie, Nantes, France.
- U1246 SPHERE "methodS in Patient-centered outcomes and HEalth ResEarch", Université de Nantes, Université de Tours, INSERM, Nantes, France.
- Nantes Université, CHU Nantes, Service Douleur, Soins palliatifs et de Support, Unité de Soins Palliatifs, Nantes, France.
- Nantes Université, CHU Nantes, Service Douleur, Soins palliatifs et de Support, Centre de traitement de la douleur, Nantes, France.
- Nantes Université, CHU Nantes, Service de pharmacologie clinique, Nantes, France.
ORCID-Profile: Pierre Nizet, Adrien Evin, Jean-François Huon
Zitieren
APA
Nizet, P., Deme, L., Evin, A., Kuhn, E., Nizard, J., Victorri Vigneau, C., & Huon, J. F. (2025). Determinants of successful opioid deprescribing: Insights from French pain physicians—A qualitative study. Pain Practice. https://doi.org/10.1111/papr.13409
Vancouver
Nizet P, Deme L, Evin A, Kuhn E, Nizard J, Victorri Vigneau C, et al. Determinants of successful opioid deprescribing: Insights from French pain physicians—A qualitative study. Pain Practice. 2025. doi:10.1111/papr.13409
BibTeX
@article{Nizet2025,
author = {Nizet, Pierre and Deme, Laure and Evin, Adrien and Kuhn, Emmanuelle and Nizard, Julien and Victorri Vigneau, Caroline and Huon, Jean-François},
title = {Determinants of successful opioid deprescribing: Insights from French pain physicians—A qualitative study},
journal = {Pain Practice},
year = {2025},
doi = {10.1111/papr.13409}
}
EUVIMED